Roche Holding AG (SWX:ROG)
322.30
+1.60 (0.50%)
Inactive · Last trade price on Mar 16, 2026
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
613.62K CHF
Profits / Employee
124.75K CHF
Market Cap
257.46B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Roche Holding AG News
- 3 hours ago - Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection - PRNewsWire
- 3 hours ago - Roche chairman likens US tariff policy to 'blackmail' - Reuters
- 2 days ago - FDA Grants Priority Review For Roche's NDA For Giredestrant In Breast Cancer - Nasdaq
- 2 days ago - Roche Announces FDA's Filing Acceptance Under Priority Review For Giredestrant - Nasdaq
- 2 days ago - FDA Accepts New Drug Application for Genentech's Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting - Business Wire
- 2 days ago - FDA accepts New Drug Application for Roche's giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting - GlobeNewsWire
- 3 days ago - Genentech Presents Updated Clinical Results Of Enicepatide And Petrelintide At ADA 2026 - Nasdaq
- 3 days ago - Louth GAA FL Division 2 Round-up: Walsh in sizzling form for Fechins as Roche sit top - Independent Ireland